94 related articles for article (PubMed ID: 2508983)
1. Prostacyclin mediates antiaggregatory and hypotensive actions of endothelin in anaesthetized beagle dogs.
Hermán F; Magyar K; Chabrier PE; Braquet P; Filep J
Br J Pharmacol; 1989 Sep; 98(1):38-40. PubMed ID: 2508983
[TBL] [Abstract][Full Text] [Related]
2. Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin.
Filep JG; Hermán F; Battistini B; Chabrier PE; Braquet P; Sirois P
J Cardiovasc Pharmacol; 1991; 17 Suppl 7():S216-8. PubMed ID: 1725337
[TBL] [Abstract][Full Text] [Related]
3. The in vivo antiaggregatory action of endothelin-1 is not mediated through the endothelin ETA receptor.
Hermán F; Yano M; Filep JG
Eur J Pharmacol; 1993 May; 236(1):143-6. PubMed ID: 8319738
[TBL] [Abstract][Full Text] [Related]
4. In vivo antiaggregatory action of platelet-activating factor in beagle dogs: role for prostacyclin.
Hermán F; Magyar K; Filep JG
Thromb Haemost; 1991 Mar; 65(3):296-9. PubMed ID: 2048053
[TBL] [Abstract][Full Text] [Related]
5. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
Hermán F; Hadházy P; Magyar K
Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
[TBL] [Abstract][Full Text] [Related]
6. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
[TBL] [Abstract][Full Text] [Related]
7. Effects of PGI2, CH-7284 and CH-7384 on spontaneous platelet aggregation and blood pressure of anaesthetized beagles.
Hermán F; Malomvölgyi B; Hadházy P; Magyar K
Biomed Biochim Acta; 1988; 47(10-11):S113-6. PubMed ID: 3073758
[TBL] [Abstract][Full Text] [Related]
8. Endothelins induce prostacyclin release in both vascular and non-vascular tissue.
Mattera GG; Catalioto RM; Criscuoli M; Subissi A
Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):410-5. PubMed ID: 7845478
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
Thiemermann C; Lidbury PS; Thomas GR; Vane JR
J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-3: selectivity as an anti-aggregatory peptide in vivo.
Lidbury PS; Thiemermann C; Thomas GR; Vane JR
Eur J Pharmacol; 1989 Jul; 166(2):335-8. PubMed ID: 2676565
[TBL] [Abstract][Full Text] [Related]
11. Effects of prostacyclin analogues on platelet aggregation and blood pressure of anaesthetized beagle dogs.
Hermán F; Hadházy P; Magyar K; Kovács G
Prog Clin Biol Res; 1987; 242():101-6. PubMed ID: 3313407
[No Abstract] [Full Text] [Related]
12. Endothelin-1 inhibits platelet aggregation in vivo: a study with 111indium-labelled platelets.
Thiemermann C; May GR; Page CP; Vane JR
Br J Pharmacol; 1990 Feb; 99(2):303-8. PubMed ID: 2183912
[TBL] [Abstract][Full Text] [Related]
13. In vivo antiaggregatory effect of BM 13.177 on the spontaneous platelet aggregation in anaesthetized beagle dogs.
Hermán F; Malomvölgyi B; Hadházy P; Magyar K
Biomed Biochim Acta; 1988; 47(10-11):S90-3. PubMed ID: 3073773
[TBL] [Abstract][Full Text] [Related]
14. Renal actions of endothelin: interaction with prostacyclin.
Chou SY; Dahhan A; Porush JG
Am J Physiol; 1990 Oct; 259(4 Pt 2):F645-52. PubMed ID: 2221102
[TBL] [Abstract][Full Text] [Related]
15. Systemic levels of 6-keto-prostaglandin F1 alpha following administration of inhaled aerosolized prostacyclin.
van Heerden PV
Anaesth Intensive Care; 1997 Dec; 25(6):701-3. PubMed ID: 9452859
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
[TBL] [Abstract][Full Text] [Related]
18. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
[TBL] [Abstract][Full Text] [Related]
19. Effects of aspirin dose escalation on platelet function and urinary thromboxane and prostacyclin levels in normal dogs.
McLewee N; Archer T; Wills R; Mackin A; Thomason J
J Vet Pharmacol Ther; 2018 Feb; 41(1):60-67. PubMed ID: 28664658
[TBL] [Abstract][Full Text] [Related]
20. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T
Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
